Roivant Sciences Income Statement (2020-2026) | ROIV

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
7.74M13.99M46.06M4.32M12.53M33.90M21.62M3.65M23.69M7.99M4.47M21.48M2.17M1.57M5.74M
Gross Profit (Quarter)
6.99M7.61M37.56M2.59M8.89M24.95M17.41M3.42M22.29M7.78M4.24M20.78M2.02M1.46M4.78M
Operating items
Research & Development (Quarter)
78.52M132.10M347.96M135.83M132.00M393.36M125.13M114.79M332.35M120.51M143.07M405.18M152.92M164.57M482.87M
Selling, General & Administrative (Quarter)
82.75M437.78M636.06M149.07M157.66M475.00M156.19M88.58M308.03M99.89M202.88M444.32M134.02M143.12M452.22M
Other Operating Expenses (Quarter)
0.85M66.47M1.73M16.71M14.17M27.85M0.21M0.23M0.71M0.15M0.11M0.96M
Operating Expenses (Quarter)
162.12M698.42M1,130.90M286.63M293.30M975.06M298.04M217.54M668.24M220.61M346.19M850.20M287.09M307.80M936.05M
Operating Income (Quarter)
-154.39M-684.43M-1084.84M-282.31M-280.77M-941.15M-276.41M-213.89M5,127.45M-102.23M-341.71M-718.33M-284.92M-306.23M-930.31M
EBIT (Quarter)
-154.39M-684.43M-1084.84M-282.31M-280.77M-941.15M-276.41M-213.89M5,127.45M-102.23M-341.71M-718.33M-284.92M-306.23M-930.31M
Non-operating items
Non Operating Investment Income (Quarter)
-8.62M443.75M443.75M-24.55M-54.68M-53.28M-7.56M-45.85M-63.88M15.23M48.38M42.29M-19.12M128.50M130.97M
Interest & Investment Income (Quarter)
0.06M0.20M1.98M5.67M17.90M16.71M14.30M62.97M72.13M69.77M203.75M0.47M2.58M136.93M
Other Non Operating Income (Quarter)
0.13M-1.08M-5.95M18.09M4.59M12.76M17.35M-3.61M-1.45M-7.88M-11.21M-5.69M-8.56M
Non Operating Income (Quarter)
-2.20M2.84M-5.95M18.09M
Net income details
EBT (Quarter)
-100.98M-225.24M-632.27M-349.79M-313.76M-1045.62M-326.09M-241.41M5,153.55M-19.64M-224.38M-478.54M-269.26M-159.04M-718.67M
Tax Provisions (Quarter)
0.09M0.40M0.53M4.00M2.17M8.98M1.75M3.24M27.28M11.96M12.46M-25.57M4.65M7.00M34.98M
Profit After Tax (Quarter)
-101.08M-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-331.12M5,154.47M57.49M-279.92M169.38M-273.91M-166.04M-753.65M
Income from Non-Controlling Interests (Quarter)
-18.89M-17.16M-57.60M-21.98M-24.33M-79.19M-36.03M-26.79M-86.34M-37.81M-49.74M-138.85M-50.56M-52.52M-150.89M
Income from Continuing Operations (Quarter)
-101.08M-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-244.64M5,126.27M-31.60M-236.84M-452.97M-273.91M-166.04M-753.65M
Income from Discontinued Operations (Quarter)
0.52M3.90M0.69M0.80M-0.86M
Consolidated Net Income (Quarter)
-101.08M-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M
Income towards Parent Company (Quarter)
-101.08M-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M
Net Income towards Common Stockholders (Quarter)
-101.08M-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M
Additional items
EPS (Basic) (Quarter)
-0.46-0.35-0.92-0.51-0.45-1.48-0.43-0.11-0.280.12-0.060.52
EPS (Diluted) (Quarter)
-0.16-0.35-0.92-0.51-0.45-1.48-0.43-0.11-0.270.11-0.060.52
Shares Outstanding (Quarter)
222.08M650.23M686.59M669.75M695.88M699.89M713.32M712.79M759.27M770.23M800.59M783.25M735.82M735.47M722.72M725.40M680.29M680.95M696.86M693.86M
Shares Outstanding (Diluted) (Quarter)
649.86M650.23M686.59M669.75M695.88M699.89M713.32M712.79M759.27M770.23M844.46M831.05M781.63M735.47M722.72M725.40M680.29M680.95M696.86M693.86M
EBITDA (Quarter)
-154.39M-684.43M-1084.84M-282.31M-280.77M-941.15M-276.41M-213.89M5,127.45M-102.23M-341.71M-718.33M-284.92M-306.23M-930.31M
Interest Expenses (Quarter)
2.51M13.33M5.57M20.65M11.86M11.32M19.39M11.68M9.55M9.30M27.60M11.56M81.40M115.00M113.20M701.22M0.18M0.07M1,596.93M
Tax Rate (Quarter)
-0.09-0.18-0.08-1.14-0.69-0.86-0.54-1.340.53-60.91-5.555.34-1.73-4.40-4.87